Tratamiento con inmunoglobulinas intravenosas en el fracaso reproductivo de repetición sin causas conocidas de infertilidad

Lucía Velasco Roces

doi:10.7399/fh.2016.40.4.10488

Tratamiento con inmunoglobulinas intravenosas en el fracaso reproductivo de repetición sin causas conocidas de infertilidad

Lucía Velasco Roces

Resumen

Palabras clave

Texto completo:

PDF

Referencias

Janosević DR1, Lilić V, Basić H, Pavlović AT, Stefanović M and Milosević J. Decidual natural killer cells in recurrent spontaneous abortions]. Vojnosanit 2011 Jan;68(1):41-5.

Bansal AS, Bajardeen B and Thum MY. The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J Reprod Immunol. 2012 Jan;93(1):41-51

Ramos-Medina R, García-Segovia A, León JA, Alonso B, Tejera-Alhambra M, Gil J et al. New decision-Tree Model for fdefiniting the risk of reproductive failure. Ramos-Medina R, Am J Reprod Immunol. 2013 Jul;70(1):59-68.

Li J, Chen Y, Liu C, Hu Y and Li L. Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: a systematic review and a meta-analysis. Am J Reprod Immunol. 2013 Dec;70(6):434-47.

Moraru M, Carbone J, Alecsandru D, García-Segovia A, Gil J, Alonso B et al.Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells. Am J Reprod Immunol. 2012 Jul;68(1):75-84.

De Stefano V, Leone G (1995). «Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia». Haematologica 80 (4): 344–56

DOI: http://dx.doi.org/10.7399%2Ffh.2016.40.4.10488